share_log

Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results

SEC announcement ·  Mar 5 05:26
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.